Abstract
BOTH the estrogen and progestogen in most of the oral contraceptive agents are 17-α-alkyl-substituted steroids.1 Because compounds of this structure may produce cholestasis2 , 3 it is not surprising that disturbed liver function has been reported in patients using oral contraceptives. The purpose of this report is to review the subject of the hepatic dysfunction induced by these agents, and to consider both the possible pathogenesis of the disturbance and its clinical implications.Clinical ReportsAbout 40 cases of jaundice attributed to 5 different oral contraceptives have been reported. Although most of the initial reports were from Scandinavia4 5 6 7 8 9 10 11 12 reports from England,13 , 14 Canada, . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
